How many insider declarations has Rieger Jayson filed?

Rieger Jayson has filed 4 public insider declarations with SEC (Form 4).

What is Rieger Jayson's role?

Rieger Jayson's reported role is not specified by the regulator across the filings.

Which companies does Rieger Jayson report trades for?

Rieger Jayson reports trades for Verrica Pharmaceuticals Inc..

What is Rieger Jayson's declared buy vs sell volume?

Across the available history, declared buys total 456k€ and disposals 0.

← Executives ★ Sign in to follow

RJ

Rieger Jayson

CEO

·SEC (Form 4)

Verrica Pharmaceuticals Inc.

累计流向

0

申报总数

0

公司

€456,203

▲ 买入（4 笔）

—

▼ 卖出（0 笔）

内部人交易记录

其他

已披露买入

4

已披露卖出

0

尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。

信号历史

无可用的信号评分。

Browse the complete record of transactions filed by Rieger Jayson. Insider active across 1 company, notably Verrica Pharmaceuticals Inc.. In total, 4 disclosures have been recorded. Split: 4 buys · 0 sell. Total volume traded: €456k. Activity tracked since 25 November 2025. The latest transaction was disclosed on 14 August 2026 (Acquisition). Regulator: SEC (Form 4). The full history is accessible without signup.

Companies and markets linked to Rieger Jayson

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Verrica Pharmaceuticals Inc. (US)

申报4 总计

▲

Rieger Jayson

CEO and President高管2026年8月14日Verrica Pharmaceuticals Inc.

US$101,2000SEC ↗

20,000 股@ US$5.06Common StockSEC:0002043558-26-000005:0

标准退出：2026年11月12日 (T+90)

▲

Rieger Jayson

CEO and President高管2026年8月17日Verrica Pharmaceuticals Inc.

US$24,5500SEC ↗

5,000 股@ US$4.91Common StockSEC:0002043558-26-000005:1

标准退出：2026年11月15日 (T+90)

▲

Rieger Jayson

CEO and President高管2025年11月25日Verrica Pharmaceuticals Inc.

US$400,11452SEC ↗

94,311 股@ US$4.2425100.0% 占其流量Common StockSEC:0002043558-25-000003:0

标准退出：2026年2月23日 (T+90)

▲

Rieger Jayson

CEO and President高管2024年11月22日Verrica Pharmaceuticals Inc.

0SEC ↗

280,898 股Common StockSEC:0001415889-24-027711:0

标准退出：2025年2月20日 (T+90)

4 条申报中的 4 条

InsidersTradesSigma

← Executives ★ Sign in to follow

RJ

Rieger Jayson

CEO

·SEC (Form 4)

Verrica Pharmaceuticals Inc.

累计流向

0

申报总数

0

公司

€456,203

▲ 买入（4 笔）

—

▼ 卖出（0 笔）

内部人交易记录

其他

已披露买入

4

已披露卖出

0

尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。

信号历史

无可用的信号评分。

Browse the complete record of transactions filed by Rieger Jayson. Insider active across 1 company, notably Verrica Pharmaceuticals Inc.. In total, 4 disclosures have been recorded. Split: 4 buys · 0 sell. Total volume traded: €456k. Activity tracked since 25 November 2025. The latest transaction was disclosed on 14 August 2026 (Acquisition). Regulator: SEC (Form 4). The full history is accessible without signup.